Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance - Poll - MDSpire

Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance

  • By

  • Maliheh Hasannia

  • Mahdi Abounoori

  • Fatemeh Mahmoudian

  • Maryam Shirzad

  • Abbas Rahdar

  • Selamu Duguna

  • Sadanand Pandey

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance

  • by Maliheh Hasannia, Mahdi Abounoori, Fatemeh Mahmoudian, Maryam Shirzad, Abbas Rahdar, Selamu Duguna, Sadanand Pandey

  • June 17, 2026

Related Content

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma

Enhanced differentiation of breast lesions through integration of microvascular flow imaging and machine learning algorithms

Optical coherence tomography features and visual prognosis in vitreoretinal lymphoma: a structured phenotyping study